Wu C - Search Results

1

Genomic and GeneChip expression profiling reveals the inhibitory effects of Amorphophalli Rhizoma in TNBC cells.

Wu C, Chen M, Zhang Q, Yu L, Zhu J, Gao X. Wu C, et al. J Ethnopharmacol. 2019 May 10;235:206-218. doi: 10.1016/j.jep.2019.02.004. Epub 2019 Feb 4. J Ethnopharmacol. 2019. PMID: 30731183

2

Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.

Wu C, Qiu S, Liu P, Ge Y, Gao X. Wu C, et al. J Ethnopharmacol. 2018 Jan 30;211:89-100. doi: 10.1016/j.jep.2017.09.033. Epub 2017 Sep 27. J Ethnopharmacol. 2018. PMID: 28962890

3

Comparative pharmacokinetics of six coumarins in normal and breast cancer bone-metastatic mice after oral administration of Wenshen Zhuanggu Formula.

Chen W, Li J, Sun Z, Wu C, Ma J, Wang J, Liu S, Han X. Chen W, et al. Among authors: wu c. J Ethnopharmacol. 2018 Oct 5;224:36-44. doi: 10.1016/j.jep.2018.05.031. Epub 2018 May 24. J Ethnopharmacol. 2018. PMID: 29803570

4

Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.

Wu C, Chen M, Sun Z, Ye Y, Han X, Qin Y, Liu S. Wu C, et al. J Ethnopharmacol. 2019 Mar 25;232:145-154. doi: 10.1016/j.jep.2018.12.023. Epub 2018 Dec 18. J Ethnopharmacol. 2019. PMID: 30576770

5

Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes.

Li H, Wu C, Liu Y, Zhang S, Gao X. Li H, et al. Among authors: wu c. BMC Complement Altern Med. 2019 Sep 4;19(1):240. doi: 10.1186/s12906-019-2651-0. BMC Complement Altern Med. 2019. PMID: 31484532 Free PMC article.

6

Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization.

Yang R, Xie Y, Li Q, Ye Y, Shi Y, Zhao X, Wu C, Xu Y, Wang R, Zhang Y, Yang X, Han X, Liu S. Yang R, et al. Among authors: wu c. Biomed Pharmacother. 2021 Sep;141:111883. doi: 10.1016/j.biopha.2021.111883. Epub 2021 Jul 9. Biomed Pharmacother. 2021. PMID: 34246955 Free article.

7

GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells.

Gao X, Yang Z, Xu C, Yu Q, Wang M, Song J, Wu C, Chen M. Gao X, et al. Among authors: wu c. Ann Transl Med. 2022 Mar;10(6):274. doi: 10.21037/atm-22-757. Ann Transl Med. 2022. PMID: 35433966 Free PMC article.

8

ICAM1 promotes bone metastasis via integrin-mediated TGF-β/EMT signaling in triple-negative breast cancer.

Chen M, Wu C, Fu Z, Liu S. Chen M, et al. Among authors: wu c. Cancer Sci. 2022 Nov;113(11):3751-3765. doi: 10.1111/cas.15532. Epub 2022 Aug 26. Cancer Sci. 2022. PMID: 35969372 Free PMC article.

9

Tumor-derived exosomal ICAM1 promotes bone metastasis of triple-negative breast cancer by inducing CD8+ T cell exhaustion.

Chen M, Fu Z, Wu C. Chen M, et al. Among authors: wu c. Int J Biochem Cell Biol. 2024 Oct;175:106637. doi: 10.1016/j.biocel.2024.106637. Epub 2024 Aug 13. Int J Biochem Cell Biol. 2024. PMID: 39147124

10

OSU-T315 overcomes immunosuppression in triple-negative breast cancer by targeting the ILK/NF-κB signaling pathway to enhance immunotherapeutic efficacy.

Wang Y, Qin Y, Wu C, Chen J, Zhang Y, Chen Y, Xie X, Gao X, Sun C, Liu S. Wang Y, et al. Among authors: wu c. Int Immunopharmacol. 2024 Nov 7;143(Pt 3):113530. doi: 10.1016/j.intimp.2024.113530. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39515039 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,763 results

Search Page

Filters